RecruitingNot ApplicableNCT05224986

Lifestyle Patterns and Glycemic Control


Sponsor

Columbia University

Enrollment

34 participants

Start Date

Jan 19, 2022

Study Type

INTERVENTIONAL

Conditions

Summary

The goal of the proposed study is to evaluate the feasibility and initial efficacy of stabilizing lifestyle behaviors to improve glucose control and body composition in patients with pre-diabetes. The investigator proposes that following stable lifestyle behaviors will improve patients' glucose control, body composition, and liver fat. The results from this study has the potential to impact clinical practice and patient care.


Eligibility

Min Age: 25 Years

Inclusion Criteria5

  • Pre-diabetic kg/m2 (hemoglobin A1c 5.7-6.9%)
  • years or older
  • BMI between 25-39.9 kg/m2
  • Sleep duration ≥6 hours a night assessed with wrist actigraphy (for 14 nights)
  • Variable bedtime, SD≥45 minutes.

Exclusion Criteria11

  • Chronic Kidney Disease (GFR<60)
  • Uncontrolled hypertension (≥160/100 mmHg)
  • Obstructive Sleep Apnea
  • Psychiatric or neurological disorder
  • Prevalent cardiovascular disease
  • Dyslipidemia (triglycerides≥200 mg/dL)
  • Medications that affect insulin sensitivity, glucose concentrations, and body weight
  • Non-day or rotating shift workers
  • Travel across time zones
  • Active participation in weight loss program or within past 3 months
  • Current or past alcohol/drug abuse

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

BEHAVIORALFixed Schedule

Participants will be asked to maintain a fixed schedule for 12 weeks.


Locations(1)

Columbia University Irving Medical Center

New York, New York, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05224986


Related Trials